William Blair Investment Management
AMED

William Blair Investment Management’s Amedisys AMED Stock Holding History

William Blair Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-720,310
Closed -$124M – 403
2022
Q1 		$124M Sell
720,310
-28,958
-4% -$4.33M 0.37% 92
2021
Q4 		$121M Sell
749,268
-14,380
-2% -$2.31M 0.33% 101
2021
Q3 		$114M Buy
763,648
+29,075
+4% +$6.04M 0.32% 102
2021
Q2 		$180M Sell
734,573
-14,075
-2% -$3.69M 0.56% 70
2021
Q1 		$198M Sell
748,648
-1,865
-0.2% -$526K 0.64% 61
2020
Q4 		$220M Sell
750,513
-9,552
-1% -$2.45M 0.73% 43
2020
Q3 		$180M Sell
760,065
-226,937
-23% -$51.6M 0.7% 50
2020
Q2 		$196M Buy
987,002
+16,969
+2% +$3.16M 0.8% 33
2020
Q1 		$178M Sell
970,033
-100,121
-9% -$17.8M 0.87% 30
2019
Q4 		$179M Buy
1,070,154
+57,572
+6% +$8.56M 0.71% 44
2019
Q3 		$133M Buy
1,012,582
+24,049
+2% +$3.13M 0.57% 59
2019
Q2 		$120M Buy
988,533
+893,253
+938% +$106M 0.5% 69
2019
Q1 		$11.7M Buy
95,280
+23,645
+33% +$2.97M 0.05% 307
2018
Q4 		$8.39M Buy
+71,635
New +$8.44M 0.04% 321
2017
Q3 		– Sell
-1,463,746
Closed -$91.9M – 436
2017
Q2 		$91.9M Sell
1,463,746
-168,496
-10% -$9.81M 0.33% 99
2017
Q1 		$83.4M Buy
1,632,242
+122,305
+8% +$5.83M 0.32% 102
2016
Q4 		$64.4M Buy
1,509,937
+480,150
+47% +$20.4M 0.26% 125
2016
Q3 		$48.9M Buy
1,029,787
+293,355
+40% +$14.6M 0.18% 150
2016
Q2 		$37.2M Sell
736,432
-76,908
-9% -$3.88M 0.15% 160
2016
Q1 		$39.3M Buy
+813,340
New +$31.4M 0.16% 151

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair Investment Management's AMED Position: Q2 2022 in Review

William Blair Investment Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 720,310 shares — an estimated $124M sold.

William Blair Investment Management first reported a position in AMED in Q1 2016 and held it in 20 quarters. The position peaked at $220M in Q4 2020. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • William Blair Investment Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • William Blair Investment Management sold 720,310 Amedisys shares in Q2 2022, an estimated $124M.
  • William Blair Investment Management first reported a position in Amedisys in Q1 2016 and held it in 20 quarters.
  • William Blair Investment Management's Amedisys position peaked at $220M in Q4 2020.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on William Blair Investment Management's 13F filing for Q2 2022, filed 10 Aug 2022.